S 48168 (ARM 210) for the Treatment of RYR1-related Myopathies (RYR1-RM)
Clinical trial NCT04141670 · COMPLETED
Trial details
- NCT number
- NCT04141670
- Sponsor
- RyCarma Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-25
- Primary completion
- 2022-12-30
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.